Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease
Authors:
- Javier LlorcaJLJavier Llorca
- Jon InfanteJIJon Infante
- Eloy Rodríguez-RodríguezEREloy Rodríguez-Rodríguez
- Coro Sánchez-QuintanaCSCoro Sánchez-Quintana
- Pascual Sánchez-JuanPSPascual Sánchez-Juan
- José BercianoJBJosé Berciano
- Onofre CombarrosOCOnofre Combarros
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 401 (1-2) , 171-173
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetesBiochemical and Biophysical Research Communications, 2005
- VEGF polymorphisms and severity of atherosclerosisJournal of Medical Genetics, 2005
- Vascular endothelial growth factor gene variability is associated with increased risk for ADAnnals of Neurology, 2005
- Atherosclerosis and ADNeurology, 2005
- Decreased Release of the Angiogenic Peptide Vascular Endothelial Growth Factor in Alzheimer’s Disease: Recovering Effect with Insulin and DHEA SulfateDementia and Geriatric Cognitive Disorders, 2004
- VEGF links hippocampal activity with neurogenesis, learning and memoryNature Genetics, 2004
- Androgen Receptor YAC Transgenic Mice Recapitulate SBMA Motor Neuronopathy and Implicate VEGF164 in the Motor Neuron DegenerationNeuron, 2004
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathNature Genetics, 2003
- A Common Polymorphism in the 5′-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 DiabetesDiabetes, 2002
- Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyThe Lancet, 1997